Board meeting scheduled for May 14, 2026 to approve audited standalone financial results for FY, HY, and Q4 ended March 31, 2026.
Board to consider potential issuance of equity shares or other securities via preferential issue, rights issue, or other methods.
Trading window for designated persons closed from April 1, 2026 until 48 hours after results declaration.